Ming Cheah, PhD, is a biotech investor at Goldman Sachs focusing on private-stage investments in emerging therapeutics companies. With over nine years of experience in life science R&D, finance, and strategy, they previously served as a consultant at McKinsey & Company and held various roles, including Board Observer at multiple biotech firms. Ming earned their PhD in Immunology from Stanford University and holds both a Bachelor’s and Master’s degree from Yale University. They are passionate about advancing transformational science through intelligent capital investment.
This person is not in the org chart
This person is not in any teams
This person is not in any offices